Caution: Beware of Scam Websites

Several websites NOT affiliated with AASLD are posting information about housing and registration for The Liver Meeting® 2019. The only groups authorized to offer these services are onPeak and AASLD-IGH for housing, and CDS for registration.
To ensure your housing and registration needs are guaranteed, ONLY use the information on our website.
Add to Calendar 2019-11-08 08:00:00 2019-11-12 13:00:00 The Liver Meeting The Liver Meeting® is the annual must-attend event bringing together 9,500 attendees from around the world to exchange the latest research, discuss new developments in treatment outcomes, and network with other experts in the field. Boston, MA United States AASLD America/Chicago public

Important Registration and Housing Dates

  • AASLD Member Registration and Housing Opens: July 24, 2019
  • General Attendee Registration and Housing Opens: July 31, 2019


  • 6:30 am – 7:30 pm
    Registration Hours

  • 8:00 am – 10:00 am
    Special Interest Group Programming
    Bile Acid Signaling and Cholestatic Liver Diseases (Cholestatic, Autoimmune and Biliary Diseases SIG)
    Drug Induced Liver Injury: Assessing Risk and Predicting Outcome (Hepatotoxicity SIG)
    NAFLD Progression: A Cross Talk with Microbiome (Non-alcoholic Fatty Liver Disease SIG)

  • 8:00 am – 12:00 pm
    Special Interest Group Programming
    Acute and Chronic Kidney Failure in Cirrhosis: Mechanisms to Management (Acute on Chronic Liver Failure SIG and Portal Hypertension SIG)

  • 8:00 am – 3:30 pm
    AASLD / ILTS Transplant Course
    The Critically Ill Patient and Challenges in Liver Transplantation

  • 8:00 am – 4:00 pm
    AASLD / ASGE Endoscopy Course
    New Endoscopic Frontiers in Liver Disease

  • 8:00 am – 5:30 pm
    Poster Session I (Presentation Time: Noon – 1:30 pm)

  • 9:00 am – 12:00 pm
    Clinical Research Workshop
    Microbiome as a Model of Clinical Research: From Stool to Study to Treatment

  • 10:30 am – 12:30 pm
    Special Interest Group Programming
    Novel Approaches to Study and Treat Liver Fibrosis: From Bedside to Bench, and Bed Again? (Liver Fibrosis SIG)
    Improving the Care Continuum for Chronic HCV Infection in 2019 (Hepatitis C SIG)
    Population Screening for Liver Disease Worldwide (Public Health/ Healthcare Delivery SIG)

  • 1:00 pm – 4:00 pm
    AASLD / NASPGHAN Pediatric Symposium
    Acute Liver Failure

  • 2:00 pm – 4:00 pm
    Career Development Workshop

  • 2:00 pm – 4:00 pm
    Special Interest Group Programming
    Controversies in Clinical Hepatology (Clinical Practice SIG)
    Update on Screening, Diagnosis and Management of HBV-related HCC (Hepatitis B SIG)
    Regenerative Medicine and the Bio-Artificial Liver (Liver Cell Biology in Hepatic Diseases SIG)

  • 4:30 pm – 6:30 pm
    Academic Debates


  • 6:30 am – 7:30 pm
    Registration Hours

  • 6:45 am – 7:45 am
    Early Morning Workshops

  • 8:00 am – 5:00 pm
    Basic Science Symposium
    Current Trends in Liver Regeneration and Repair

  • 8:00 am – 5:00 pm
    Postgraduate Course
    Precision Hepatology in Clinical Practice

  • 11:45 am – 1:15 pm
    Meet-the-Professor Luncheons

  • 12:00 pm – 1:30 pm
    Meet-the-Professor Luncheons

  • 1:00 pm – 5:00 pm
    Transplant Surgery Workshop
    Liver Transplantation for NASH: Optimizing Outcomes

  • 2:00 pm – 7:30 pm
    Poster Session II (Presentation Time: 5:30 pm – 7:00 pm)

  • 5:00 pm – 7:30 pm
    Exhibits Open

  • 5:00 pm – 7:30 pm
    Opening Reception

  • 7:30 pm – 10:00 pm
    Industry-supported Satellite Symposia​



  • 6:30 am – 6:00 pm
    Registration Hours

  • 6:45 am – 7:45 am
    Early Morning Workshops

  • 7:00 am – 8:00 am
    Academic Skills: Grant Writing

  • 8:00 am – 9:30 am
    Liver Transplant Plenary I

  • 8:00 am – 12:00 pm
    Basic Research Workshop
    A New Era of Genomics and Biomarkers in Hepatocellular Carcinoma

  • 8:00 am – 12:00 pm
    Hepatology Associates Course

  • 8:00 am – 5:30 pm
    Poster Session III (Presentation Time: 12:30 pm – 2:00 pm)

  • 8:30 am – 10:00 am
    Parallel Sessions

  • 9:30 am – 10:00 am
    Thomas E. Starzl Transplant Surgery State-of-the-Art Lecture

  • 9:30 am – 3:00 pm
    Exhibits Open

  • 10:30 am – 12:00 pm
    Liver Transplant Plenary II

  • 10:30 am – 12:00 pm
    Parallel Sessions

  • 10:30 am – 12:30 pm
    Special Interest Group Programming
    Emerging Therapies and Current Clinical Trials for Alcoholic Hepatitis (Alcoholic Liver Disease SIG)

  • 10:30 am – 12:30 pm
    Diversity Workshop
    Social Innovation: Solution-based Responses to disparities in Liver Diseases and Liver Transplantation

  • 2:00 pm – 3:30 pm
    General Hepatology Update

  • 2:00 pm – 3:30 pm
    Parallel Sessions

  • 2:00 pm – 4:00 pm
    Maintenance of Certification (MOC) Update

  • 2:00 pm – 4:00 pm
    Value-based Medicine in Hepatology
    Defining the Role of Hepatologists in Value-based Care

  • 2:00 pm – 4:00 pm
    Special Interest Group Programming
    Obesity, Metabolic Syndrome and HCC (Hepatobiliary Neoplasia SIG)
    Multi-disciplinary Approach in Reducing Readmissions (Hepatology Associates SIG)

  • 4:00 pm – 4:15 pm
    Presidential Address

  • 4:00 pm – 6:00 pm
    Transplant Hepatology Fellowship Program Directors Workshop
    Defining the Hepatology Workforce Study in the US

  • 4:15 pm – 4:45 pm
    President’s Choice Lecture

  • 4:15 pm – 6:15 pm
    AASLD / APASL Joint Symposium
    Acute on Chronic Liver Failure

  • 4:30 pm – 6:00 pm
    Parallel Sessions

  • 6:30 pm – 9:00 pm
    Industry-supported Satellite Symposia


  • 6:30 am – 6:00 pm
    Registration Hours

  • 6:45 am – 7:45 am
    Early Morning Workshops

  • 7:00 am – 8:00 am
    Academic Skills: Journal Editors Session: How to Write a Thorough Peer Review

  • 8:00 am – 9:30 am
    Presidential Plenary (Clinical)

  • 8:00 am – 5:30 pm
    Poster Session IV (Presentation Time: 12:30 pm – 2:00 pm)

  • 8:30 am – 10:00 am
    Parallel Sessions

  • 9:30 am – 10:00 am
    Distinguished Award Presentations (Distinguished Service, Achievement and Clinician Educator / Mentor Awards)

  • 9:30 am – 3:00 pm
    Exhibits Open

  • 10:00 am – 10:30 am
    Hyman J. Zimmerman Hepatotoxicity State-of-the-Art Lecture

  • 10:30 am – 12:00 pm
    Parallel Sessions

  • 10:30 am – 12:30 pm
    Advances for Practitioners
    New AASLD Guidelines: A Summary of New Recommendations for HCC, PBC and ALD

  • 11:00 am – 12:30 pm
    Presidential Plenary (Basic)

  • 2:00 pm – 2:30 pm
    Hans Popper State-of-the-Art Lecture

  • 2:00 pm – 3:30 pm
    Parallel Sessions

  • 2:00 pm – 4:00 pm
    Emerging Trends Symposium
    Microelimination of Viral Hepatitis – Positive Use in Organ Transplantation

  • 2:00 pm – 4:00 pm
    Global Forum

  • 2:00 pm – 6:00 pm
    Special Interest Group Programming
    Optimizing Allograft Health Over a Lifetime (Liver Transplantation and Surgery SIG & Pediatric Liver Disorders SIG)

  • 2:30 pm – 4:00 pm
    Late-breaking Abstract Oral Session I and Recognition Ceremony

  • 4:00 pm – 4:30 pm
    Basic Debrief

  • 4:00 pm – 5:30 pm
    Parallel Sessions

  • 4:00 pm – 6:00 pm
    Women’s Health Program
    Pregnancy in Liver Disease

  • 6:30 pm – 9:00 pm
    Industry-Supported Satellite Symposia​
  • 6:30 am – 1:30 pm
    Registration Hours

  • 8:00 am – 9:00 am
    Late-breaking Oral Abstract Session II

  • 9:00 am – 10:30 am
    Presidential Plenary (Translational)

  • 10:30 am – 11:00 am
    Leon Schiff State-of-the-Art Lecture

  • 11:00 am – 11:30 am

  • 11:30 am – 12:00 pm
    Hepatitis Debrief

  • 12:00 pm – 12:30 pm
    NAFLD Debrief

  • 12:30 pm – 1:00 pm
    Clinical Hepatology Debrief

Important Registration and Housing Dates

  • AASLD Member Registration and Housing Opens: July 24, 2019
  • General Attendee Registration and Housing Opens: July 31, 2019


Who Attends The Liver Meeting®

The Liver Meeting® is the annual must-attend event bringing together 9,500 attendees from around the world to exchange the latest research, discuss new developments in treatment outcomes, and network with other experts in the field. Our attendees include those focused on:

  • Adult and pediatric hepatology
  • Clinical, basic and translational researchers
  • Specialists who diagnose and treat liver disease, including gastroenterologists, surgeons, pathologists, anesthesiologists and radiologists
  • Primary care physicians
  • NPs, PAs, RNs, pharmacists and other allied health professionals
  • Trainees and students in all disciplines listed above


Create Your Visa Letter

Are you an international attendee to The Liver Meeting® 2019? If so, create your Visa Letter here. The logo letterhead will render correctly once the letter has been downloaded.

Travel Note

US residents: Please review the Real ID Act regarding boarding federally regulated commercial aircrafts. Depending on your state of residence, you may need to provide a second form of identification at the airport.


To save attendees time and money, AASLD negotiates the best rates with hotels near Hynes Convention Center for the conference.

Group housing is now open

Domestic and Exhibitor Groups

Domestic groups, exhibitors and international groups not requiring hotel package rates should complete the group housing request form or contact Brad Finkbeiner at

International Groups

International groups or travel agents requiring hotel package rates that include room, breakfast, porterage, taxes, gratuities, multilingual customer service assistance, or visa assistance should contact AASLD International Group Housing (AASLD-IGH) at AASLD International Group Housing or

Registration and Housing Warning – Don’t be fooled by scammers

  • Avoid Google and other search engines. Get information directly from the official The Liver Meeting® site. Scammers pay to position ads at the top of your search results, including the fraudulent sites that use the AASLD name and meeting details.
  • AASLD Official Housing Provider BadgeBook and confirm your registration / housing with AASLD. Always go directly to The Liver Meeting® site, and look for the Official Housing Provider badge. Third-party companies often illegally represent themselves as travel agencies, soliciting attendees and exhibitors, and offer to assist with hotel reservations.
  • Ignore and delete phishing emails. These emails pose as AASLD and try to entice you to disclose personal information, such as your username, password, or bank account details.
  • Ignore and delete spoofing emails. These emails use an altered email address as the sender to hide the true origin or make their emails look legitimate and lure you into clicking on links or downloading attachments. There should always be a legitimate phone number and method of contact.


Exhibitor Resources

Booth Sizes and Fees

  • Standard booth is 10 feet x 10 feet; maximum booth size is 40 feet x 40 feet
  • In-line Booth - $3,000
  • Corner Booth - $3,200
  • Island Booth - $34 per square foot
  • Nonprofit - $525

Space Assignments

Booth space will be assigned based on the order in which the applications are received beginning January 16, 2019, once exhibitors with priority points have been placed [see page 6 of the Exhibitor Prospectus for more information on priority points].

Additional Exhibitor Info

Exhibitor List



Booth: 601, 821, 606



Booth: 529

Alexion Pharmaceuticals


Booth: 200

Alexion is a global biopharmaceutical company focused on serving patients and families affected by rare diseases, including lysosomal acid lipase deficiency (LAL-D), through the innovation, development and commercialization of life-changing therapies.

Alfa Wassermann Diagnostic Technologies


Booth: 527

Allergan USA, Inc.


Booth: 201

Alnylam Pharmaceuticals


Booth: 519

Alpha-1 Foundation


Booth: 1107

American Liver Foundation


Booth: 1115

American Porphyria Foundation


Booth: 1103

Amsety LLC


Booth: 105

Asian Pacific Association for the Study of the Liver


Booth: 1105

Asociacion Latinoamericana para el Estudio del Hígado ALEH


Booth: 1117

Asociacion Mexicana De Hepatologia


Booth: 1119

Baxter Healthcare Corporation


Booth: 1208

Bayer Healthcare


Booth: 926



Booth: 222

Blue Faery: The Adrienne Wilson Liver Cancer Association


Booth: 1123



Booth: 202

Bristol-Myers Squibb


Booth: 711

CTI Clinical Trial and Consulting


Booth: 610

CVS Specialty


Booth: 216, 216

Our commitment to helping patients and their physicians manage complex drug therapies by delivering expert individualized care and unmatched, multi-channel access has made us one of the leading specialty pharmacies in the country. We provide a full-range of pharmaceutical care, dispensing the latest FDA-approved medications.

Canadian Association for the Study of the Liver

Booth: 1125

Charles River


Booth: 109

Cholangiocarcinoma Foundation, The


Booth: 1108

Chronic Liver Disease Foundation


Booth: 1126

Cochrane Hepato-Biliary Group, The


Booth: 1121

Community Liver Alliance


Booth: 1110

DiaPharma Group, Inc


Booth: 1224, 1224

Diem Direct - Hepaxa®


Booth: 426

Digestive Disease Week

Website: http://WWW.DDW.ORG

Booth: 513, 1125, 331, 104

Dova Pharmaceuticals


Booth: 221

Dynavax Technologies Corporation

Booth: 1214

ENDRA Life Sciences


Booth: 1210

Echosens North America, Inc.


Booth: 401

Eiger BioPharmaceuticals, Inc.


Booth: 515

Eisai Inc.


Booth: 722

Enanta Pharmaceuticals


Booth: 1242

European Association for the Study of the Liver (EASL)


Booth: 1113

ExeGi Pharma


Booth: 1200

Exelixis, Inc.


Booth: 429

FUJIFILM Wako Diagnostics U.S.A. Corporation


Booth: 620



Booth: 117



Booth: 209

Gastroenterology and Endoscopy News


Booth: 1226

Gastroenterology and Hepatology

Booth: 1260

Gilead Sciences, Inc.


Booth: 801, 813, 1013, 1005, 813



Booth: 325

Gore & Associates


Booth: 121

Healio Gastroenterology


Booth: 1232

HealthWell Foundation


Booth: 1104

Hepatiq, Inc.


Booth: 103

High Point Clinical Trials Center


Booth: 513



Booth: 1240

INDIGO Biosciences, Inc.


Booth: 422

Indiana University Health


Booth: 1106

Intercept Pharmaceuticals


Booth: 317, 921

KCI Biotech (SUZHOU) Inc.


Booth: 111



Booth: 1009

Covance is the world’s most comprehensive drug development company. LabCorp, our parent company, is a market leader in diagnostics with strength in the management of infectious diseases. Together, we offer a single-source solution for drug development and treatment of acute and chronic infections. Together, we improve health and improve lives.

Laboratory for Advanced Medicine


Booth: 1202

Latin American Association for the Study of the Liver


Booth: 1117

MYR Pharma

Booth: 1206

Mallinckrodt Inc.


Booth: 1264

Mayo Clinic Laboratories


Booth: 624

Medical Solutions Technologies


Booth: 1228

Novartis Pharma AG


Booth: 301

Novo Nordisk A/S


Booth: 409

OraSure Technologies


Booth: 212

PBCers Organization


Booth: 1124

Our mission is to unite people diagnosed with Primary Biliary Cholangitis (formerly known as Primary Biliary Cirrhosis), which is a progressive chronic liver disease. Our organization helps PBC patients, their care givers, friends and families cope with PBC and improve the quality of their lives through education and support.

PSC Partners Seeking a Cure


Booth: 1112

Perspectum Diagnostics LTD


Booth: 309



Booth: 511

PhoenixBio provides access to the PXB-Mouse® (chimeric mouse model featuring a humanized liver, up to 98% human hepatocyte engraftment) and PXB-cells® (human hepatocytes freshly isolated from PXB-mice) for in vivo and in vitro liver related research areas. PhoenixBio models accelerate pharmaceutical and chemical compound development by better predicting human outcomes.

Precision MedCare


Booth: 424

ProSciento, Inc.


Booth: 1234, 1234

Promethera Biosciences SA


Booth: 628

Prometheus Laboratories Inc.


Booth: 1262

Provider Solutions + Development


Booth: 1129

Research Diets, Inc.


Booth: 1230

Resoundant Inc.


Booth: 627



Booth: 208, 208

Salix Pharmaceuticals, Inc. Valeant


Booth: 717

Sanyal Biotechnology


Booth: 1246, 1246

Sanyal Biotechnology is a full-service contract research organization specializing in pre-clinical small animal model screening of drugs. Our flagship DIAMOND™ mouse develops full metabolic syndrome solely as a result of Western Diet. We have the capability to screen drugs throughout the development timeline from basic toxicology to efficacy.

Shionogi Inc.


Booth: 623

SuperSonic Imagine


Booth: 1027

Taiwan Assoication for the Study of the Liver Foundation


Booth: 1127

UPMC Transplant


Booth: 1258, 1258

Virology Education


Booth: 220

Visikol, Inc.


Booth: 333, 331



Booth: 329

Woodland Biosciences


Booth: 626

World Gastroenterology Organisation


Booth: 1109

WuXi AppTec, Inc.


Booth: 1238

Pre-register for the Newsroom by November 5th; badges will be available for pickup onsite.

The Liver Meeting® is the premier Annual Meeting in the science and practice of hepatology, including the latest findings on new drugs, novel treatments and the results from pilot and multicenter studies. Approximately 10 percent of Americans have some form of liver disease, but fortunately, the research community has made great strides in recent years in developing new treatments for patients.

The American Association for the Study of Liver Diseases appreciates your interest in covering The Liver Meeting® and is happy to provide credentialed media with complimentary press registration [link is forthcoming].

Below you will find a complete listing of the eligibility requirements, guidelines and policies for members of the press who wish to attend The Liver Meeting®. Read all of the sections below carefully, as there have been updates to our policies.

General Information

  • The Newsroom is open to credentialed media representatives only. All journalists are encouraged to pre-register by November 5 and can pick up their badges onsite at Registration.
  • AASLD does not share media lists.
  • Coffee, tea, lunch, morning and afternoon snacks, and lunch are provided in the Newsroom on a first-come, first-served basis.

Follow the meeting on social media using:, #LiverMtg19,, and

Accepted abstracts are made available to the public on the AASLD website in early October, and are published in the October supplement of HEPATOLOGY. Late-breaking abstracts will be available in the online planner of The Liver Meeting® app in mid-October, and are published in the December issue of HEPATOLOGY. Information contained in those abstracts may not be released until the abstracts appear on the AASLD website. Academic institutions, private organizations, and companies with products whose values may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an abstract on the AASLD website. However, information beyond that contained in the abstract, e.g., discussion of the abstract done as part of a scientific presentation or presentation of additional or new information that will be available at the time of the meeting is embargoed from release to the general public until 8:00 am ET Friday, November 8.

Information released prior to this day is a violation of the AASLD Abstract Embargo Policy and the abstract is subject to withdrawal from The Liver Meeting® program. Authors are responsible for notifying financial and other sponsors about this policy.

AASLD may allow for exceptions, on a case-by-case basis, to the Abstract Embargo Policy for compelled disclosures mandated by federal securities laws. However, AASLD requires the company President, General Counsel, or other appropriate official of a company seeking such an exception to attest in writing to the specific facts in support of the request, including exactly how the securities laws are implicated, with statutory citation(s). General statements of the need to comply with the law will not be considered sufficient. Requests for an exception must be sent to AASLD. AASLD requires a minimum of five (5) days from receipt of the request to evaluate the request. In granting an exception, AASLD requires the company to state in their public disclosure that the complete and final results will be presented at The Liver Meeting®. AASLD will also require the inclusion of unreleased and unique data in such a presentation at The Liver Meeting®.

Public release of a journal article relevant to the abstract will be considered an exception to the Embargo Policy if at the time of the abstract submission deadline, the decision concerning the manuscript had not been revealed to the authors.

Press Eligibility

Journalists and contributing freelancers, employed by a recognized news organization, are eligible to apply for press registration. To be eligible for press registration, media in all categories must be directly involved in the creation of news content for organizations that meet these criteria:

  • Publish original editorial news coverage in a regular news section
  • Have complete editorial freedom from advertisers, funders and/or sponsors
  • If sponsored, the outlet has multiple sponsors (no single-sponsored publications)
  • Advertisers, sponsors, paid editorial, and other funding sources are clearly identified


Bloggers will receive press credentials on a case-by-case basis. Please include a link to recent liver disease, hepatology or health care science coverage with your registration for credentials. Finally, all blogs must demonstrate the dissemination of original, editorial news coverage and editorial freedom from advertisers and/or sponsors (single-sponsored blogs will not receive credentials; blogs with advertising must have multiple advertisers clearly identified).


Photographers, videographers, and/or other members of the multimedia team accompanying credentialed news outlets may register as media and provide a link to recent coverage from their team. Further credentialing may be required during the approval process.

NOTE: AASLD has the right to inspect the credentials of anyone registering as media and reserves the right to refuse to register any individual as press.

Ineligible Registrants

The following individuals are not eligible for press registration or access to the Newsroom.

  • Individuals who receive exhibitor passes
  • Publishers or a publication's advertising, marketing, public relations, sales, circulation, or any other non-editorial representatives
  • Industry/exhibitor press officers and their public relations consultants
  • Financial or business analysts
  • Educational program developers (including CME writers and editors)
  • Trade media management personnel
  • Editors, writers, and scientific advisory board members for journals that do not have editorial news sections
  • Companies or organizations producing publications, videos, and/or other electronic media intended for internal use, marketing, advertising, financial analysis, or public relations purposes
  • Media which produce a communications vehicle that is sponsored by a single organization or whose revenue for the publication or issue of a publication depends solely on coverage of The Liver Meeting®
  • Media which produce a communications vehicle that uses the AASLD’s name or logo, or The Liver Meeting® name/logo to imply endorsement from AASLD

NOTE: AASLD prohibits the development of CME content based on information presented at its meetings. CME writers and editors, and those writers and editors working on behalf of organizations that have written CME based on AASLD meetings, are not eligible for press passes.

Prohibited Activities

  • Sales, marketing or representing a company for the purposes of obtaining advertising, subscriptions, selling photography/video production, or other products or services from any registrant or exhibitor
  • Misrepresentation of role or activities to obtain media registration
  • Sharing or distributing embargoed materials prior to the end of the embargo
  • Developing or assisting in the development of CME programs
  • Soliciting presenters and/or attendees for inclusion in CME programs
  • Publishing or posting presentation slides, live streams of meeting presentations, or sharing copyrighted meeting materials without written permission. See copyright policy in the tab below for more information.

Press Conference Policy

AASLD will hold a press conference highlighting select research coming out of The Liver Meeting®. This press conference is an opportunity for invited investigators to share their findings with members of the media. Press releases will be sent to registered press under an embargo prior to the start of the meeting.

Press conferences are not open to the public; however, one representative from each company may attend the press conference (which is held in a space distinct from the Newsroom). Company representatives must check in with Newsroom staff 30 minutes prior to the start of the conference and must remain silent through the duration of the conference (i.e., no asking or responding to questions). Additionally, company representatives may not approach media in the press conference room.

Press Conference Slate

Will be announced in October 2019.

The Liver Meeting® Access

Credentialed media have access to all general sessions, the exhibit hall and poster area, the Postgraduate Course and the Basic Science Symposium. Access to pre-conference and other ticketed events with limited enrollment are restricted to ticket holders only. Press wishing to attend these events are encouraged to purchase a ticket.

Video/Audio Recording

Filming in The Liver Meeting® Exhibit Hall and poster area is prohibited.

Television and video crews are required to check in immediately at the Newsroom each day.

Television and video crews must wear press badges. Shooting schedules must be provided to AASLD staff in the Newsroom on the first day of the meeting.

Permission of the speaker and moderator must be obtained by the journalist before recording or photographing presentations (including Posters). Artificial light and flash photography cannot be used during presentations. Handheld audio recorders and still cameras are acceptable, assuming that intellectual property copyrights (found in the above tab)are respected.

Under no circumstances may presentations be rebroadcasted.

Any images from the Meeting should be credited to The Liver Meeting® 2019.

Copyright Policy

Reproduction of materials such as abstract data, posters, presentation slides, etc. requires obtaining permission from the listed author(s) and/or presenter(s) as well as from any individual or group that may hold copyright on the material.

Requests to reproduce excerpts of abstracts or poster presentations must be through the publisher. These requests should be addressed to

Journalists violating copyright may have their press credentials denied the following year.

Use of Insignias and Logos

Insignias and logos of the AASLD, The Liver Meeting® or AASLD Foundation are proprietary marks. Use of these in any fashion, by any entity, for any purpose, is prohibited without the written permission of AASLD. The use of insignias, logos and images that mislead the intended audience to believe that a piece or production is coming from the AASLD is strictly prohibited and will result in the denial of press credentials for future meetings.

Dedicated Websites and Newsletters

If you intend to present coverage of The Liver Meeting® in a dedicated website or newsletter, please include the following disclaimer at the top of your piece: This information is brought to you by [insert organization name] and is not sponsored by, nor a part of, the American Association for the Study of Liver Diseases or The Liver Meeting®. Additionally, you may not use the AASLD or The Liver Meeting® logos or names to imply affiliation.

AASLD reserves the right to request promotional activities violating this policy be edited or removed. Failure to comply with these guidelines may result in loss of press credentials for future meetings.

Media Information for Exhibitors

  • The Newsroom is open to credentialed media representatives only. Exhibitors and public relations professionals are not allowed inside the Newsroom and are asked to refrain from loitering outside of the Newsroom.
  • The AASLD Newsroom is the only official Newsroom of The Liver Meeting®. No other Newsrooms are permitted.
  • All exhibitors are expected to comply with all rules and regulations set forth by AASLD and The Liver Meeting®.
  • AASLD does not share media lists. Media which cover The Liver Meeting® include trade and consumer media, international and US.
  • AASLD does not allow exhibitor press materials inside the Newsroom. There will be a table for these materials outside the Newsroom. Exhibitors may leave one company press kit on the table and are responsible for monitoring and refilling their supply throughout the meeting. These materials must be in reference to research being presented at the meeting and must include the corresponding abstract number. Press materials on research presented during the meeting must be given attribution to The Liver Meeting® 2019. NOTE: AASLD does not review/approve press materials. Exhibitors are responsible for reviewing and adhering to the Embargo Policy (found in the tab above) and should refrain from using the AASLD logo, The Liver Meeting® logo and should not imply endorsement from AASLD. AASLD has the right to remove press materials that do not meet these requirements. Finally, AASLD will discard any materials left on the table at the close of the meeting.
  • One representative from each company may attend the press conference (which is held in a space distinct from the Newsroom). Company representatives must check in with Newsroom staff 30 minutes prior to the start of the conference and must remain silent through the duration of the conference (i.e., no asking or responding to questions). Additionally, company representatives may not approach media in the press conference room.

Outside Press Conferences

  • Press conferences held by exhibitors or other groups (outside of AASLD’s official press conference) are considered “outside press conferences” and must be held outside of official meeting hours and outside of the convention center; groups are responsible for securing their own space. Please see affiliate meetings rules and regulations.
  • Outside press conferences may not be promoted in the Newsroom. Exhibitors can include mention of press conferences in their one press kit (left on the table outside of the Newsroom).
  • Groups planning to hold press conferences must register their conferences with Nola Gruneisen at and include the following information: Date, time, location and topic of press conference.